Clarification regarding incorrect financial figures of Novartis India Limited for Q3 2025-26 reported in Free Press Journal article dated January 28, 2026. The article has now been taken down.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India clarified that a Free Press Journal article dated January 28, 2026, contained incorrect financial figures for Q3 FY26 (quarter ended December 31, 2025). The company stated the numbers were inaccurate and not released, verified, or endorsed by them. Free Press Journal was notified of the error and has since taken down the article. Novartis directed investors and shareholders to rely only on officially published results available on BSE's website, the company's website, and newspaper advertisements in Financial Express and Navshakti published on January 29, 2026.
This is a routine clarification aimed at preventing misinformation from misleading investors. No impact on the company's actual financials or operations; shareholders should disregard the withdrawn article and refer to official disclosures.